Introducing Citeline’s TrialScope Disclose: Core Data The new TrialScope Disclose: Core Data platform consolidates clinical trial disclosure for global registries, including ClinicalTrials.gov, CTIS and jRCT.

60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB Study of Tafenoquine for Treatment of COVID-19, on ClinicalTrials.gov ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients with mild-moderate symptoms and low risk of...

Patients Rate their Clinical Trial Experience Positively, but Trial Locations Still Pose Barriers to Enrollment NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its first “Patient Perspectives on Clinical...

CISCRP Calls On US Regulators to Require Lay Language Trial Results Summaries for Patients BOSTON, July 1, 2015 (GLOBE NEWSWIRE) -- The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit, is calling on U.S. regulators to address the unmet...